References
- Levy M, Backman L, Husberg B, Goldstein R, McMillan R, Gibbs J, et al. De novo malignancy following liver transplantation: a single-center study. Transplant Proc 1993; 25: 1397–9
- Polson R J, Neuberger J, Forman D, Calne R, Williams R. De novo malignancies after liver transplantation. Transplant Proc 1988; 20: 94–7
- Mühlbacher F, Piza F. Orthotopic liver transplantation for secondary malignancies of the liver. Transplant Proc 1987; 19: 2396–8
- Cherqui D, Duvoux C, Plassa F, Gaulard P, Julein M, Fagniez P-L, et al. Lymphoproliferative disorder of donor origin in a liver transplant recipient: complete remission after drastic reduction of immunosuppression without graft loss. Transplantation 1993; 56: 1023–6
- Bleday R, Lee E, Jessurun J, Heine J, Wong D. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum 1993; 36: 908–12
- Higashi H, Yanaga K, Marsh J W, Tzakis A, Kakisoe S, Starzl T E. Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology 1990; 11: 477–80
- Casavilla A, Moysiuk Y. Esophageal complications in ortho-topic liver transplant patients. Transplantation 1991; 52: 150–1
- Vickers C R, O'Connor H J, Quintero G A, Aerts R J, Elias E, Neuberger J M. Delayed perforation of the esophagus after variceal sclerotherapy and hepatic transplantation. Gastrointest Endosc 1989; 35: 459
- Spechler S J, Robbins A H, Rubins H B, Vincent M E, Heeren T, Doos W G, et al. Adenocarcinoma and Barrett's esophagus: an overrated risk. Gastroenterology 1984; 87: 927–33
- Cameron A J, Ott B J, Payne W S. The incidence of adenocarcinoma in columnar-lines (Barrett's) esophagus. N Engl J Med 1985; 313: 857–9
- Sartori S, Nielsen I, Trevisani L, Pazzi P, Malacarne P. Barrett's esophagus after antineoplastic chemotherapy. Endoscopy 1990; 22: 152
- Sartori S, Nielsen I, Indelli M, Trevisani L, Pazzi P, Grandi E. Barrett esophagus after chemotherapy with chyclophosphamide, methotrexate and 5-fluorouacil (CMF): an iatrogenic injury. Ann Intern Med 1991; 114: 210–1
- Peters F TM, Sleijfer D T, van Imhoff G W, Kleibeuker J H. Is chemotherapy associated with development of Barrett's esophagus. Digest Dis Sci 1993; 38: 923–6
- Herrera J L, Uzel C, Mortino E, Cook C. Barret's esophagus: lack of association with adjuvant chemotherapy for localized breast carcinoma. Gastroendosc 1992; 38: 351–3
- Hoover R, Fraumeni J F. Risk of cancer in renal transplant recipients. Lancet 1973; 2: 55
- Lennard-Jones J E, Melville D M, Morson B C, Ritchie J K, Williams C B. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990; 31: 800–6
- Penn I. Cancer is a complication of severe immunosuppression in the prosttransplant period. Surg Gynecol Obstet 1986; 162: 603–10
- Renard T H, Andrews W S, Foster M E. Relationship between OKT3 administration, EBV seroconversion, and the lymphoproliferative syndrome in pediatric liver transplant recipients. Transplant Proc 1991; 23: 1473–6